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Introduction
Epilepsy is a chronic neurological disorder, and the epi-
leptic seizure (ES) is its pathognomonic sign. The disease 
chronicity and severity lead to mental comorbidities, par-
ticularly in women [1]. Psychiatric disorders, such as de-
pression and anxiety, are considered more commonly en-
countered in women with epilepsy, thus being a challeng-
ing issue in the management of epilepsy in this population 
group [2, 3].
Anxiety is caused by subjective feelings, such as worry 
and physiological responses like tachycardia, hypercorti-
solemia, and avoidance behaviors. The characteristic signs 
of anxiety include a diffuse, unpleasant and vague sense of 
fear or anxiety, accompanied by vegetative symptoms like 
headaches, sweating, palpitations, tachycardia, gastric dis-
orders, etc. It consists of two components viz. physiological 
and psychological ones. It might eventually affect thinking, 
perception and learning, thus it might potentially distort the 
perceptions and decrease the power of concentration, asso-
ciative memory and evocation [4].
Depression is defined as a mental health disorder charac-
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Abstract
Background: Mental disorders in people with epilepsy are an old problem that remains crucial nowadays. The specialized literature has reported increasingly 
significant values of anxiety and depressive disorders associated with epilepsy in women during their child bearing age. The prevalence of depression 
comorbidity related to epilepsy has accounted for 55% of cases, many of which remain undiagnosed. Anxiety exceeds the frequency of depressive cases 
by 10-15%, which tends to be milder, however showing a chronic evolution. It is important to find out the correlation between the occurrences of mental 
disorder in women with epilepsy from the Republic of Moldova. The purpose of the study was to assess the depressive and anxiety symptoms associated 
with epilepsy in women of reproductive age.
Material and methods: A retrospective cohort study was conducted on a group of 128 women with epilepsy. Patients were divided into 2 groups, with 
anxiety and depression respectively. Hospital and Anxiety Depression Scale (HADS) was applied for estimating anxiety and depression, being considered 
a priority compared to Hamilton scales, the Beck Inventory, the Zung scale.
Results: It has been proved that the disease duration and seizure recurrence are directly proportional to prevalence of depression and anxiety cases. The 
type of seizure remains a controversial topic.
Conclusions: Anxiety and depression in epilepsy patients show a heterogeneous nature due to clinical pleiomorphism. The HAD scale is effective for 
the early diagnosis of anxiety and depression in epilepsy women. 
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terized by a series of symptoms resulting in a lack of positive 
emotional well-being, such as loss of interest and pleasure 
in previously rewarding or enjoyable activities and experi-
ences, mood swings and a range of associated emotional, 
cognitive, physical and behavioral problems. The diagnosis 
of Major Depression is based on both the severity and per-
sistence of symptoms, as well as on the level of functional 
and social disabilities, which refer to psychiatry [4, 5].
The Depression and Anxiety Screening is a mandatory 
for all chronic diseases, especially in epilepsy, thus beco-
ming a medical task for neurologists and epileptologists [6].
Epidemiological data have revealed a significantly pre-
vailing rate of depression and anxiety disorders accounting 
for 50-65% of cases [7], although these indices vary depend-
ing on the research data and the development level of the 
country. The disease duration and severity influence the on-
set of these disorders. It has been proved that the prevailing 
55% of depressive disorders in epilepsy is related to drug-
resistant epilepsy, 20-30% to recurrent seizures and even a 
6-7% incidence was found in seizure-free periods [7].
However, it should be underlined that most mental dis-
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orders remain undiagnosed [8]. On the one hand, the coex-
istence of depression and anxiety in epilepsy will worsen the 
epileptogenic brain process by deepening the brain epilepti-
zation, thus increasing the ES recurrence [8]. On the other 
hand, the development of mental disorders beyond depres-
sion and anxiety is likely to result in serious mental illnesses 
and suicide attempts [8, 9]. Early diagnosis of mental disor-
ders associated with epilepsy first provides possibility to iden-
tify the risk factors for the onset of these serious disorders and 
then optimizes antiepileptic and psychiatric treatment. 
The importance of risk factors for developing depres-
sion and anxiety disorders related to epilepsy comorbidity 
is obvious and is under current research studies. The con-
clusions and recommendations of the field-related specia-
lists are quite controversial. Some authors state that disease 
chronicity, drug resistance and family history are the key 
risk factors in developing depression and anxiety disorders, 
thus disregarding the significance of epileptic seizure type 
[10]. However, most authors suggest that the main risk fac-
tors include the ES type, particularly in focal seizures, ES re-
currence, ES duration, the disease duration and hereditary 
tendency. This study was aimed to assess the risk factors for 
developing depression and anxiety in epilepsy patients and 
namely, type of seizure, its frequency, and disease duration. 
The depressive episodes, as well as anxiety disorders 
including panic attacks or different types of phobias and 
obsessive signs, might exhibit preictal, ictal, postictal and 
interictal manifestations. Depression and interictal anxiety 
are considered the most common types of mental disorders 
in epilepsy [11]. However, the comparative prevalence is not 
known yet. The interictal period is more helpful in research-
ing mental disorders related to epilepsy.
Therefore, comorbidity of epilepsy-related depressive 
disorders shows a pleomorphic nature and includes signs, 
such as anhedonia, irritability, dysphoria, emotional lability 
followed by crying spells, anxiety, no energy, pain, insom-
nia, frustration, difficulty of concentrating, etc.
Anxiety more commonly occurs during the interictal 
period, being characterized by anhedonia, anxiety, phobia, 
fatigue, turbulence, nervousness, muscle tension, paresthe-
sias, etc. Anxiety and potential panic attacks are memorized 
by patients, particularly in focal ES, thus becoming the risk 
factors or triggers for epileptic seizures.
Common symptoms of anxiety and depression related 
to epilepsy include anhedonia, depressive mood, sense of 
uselessness and guilt associated with neurovegetative signs. 
Neurologists should be mandatorily including these signs 
within the epilepsy patient’s screening follow-up. The psy-
chic signs are assessed via the well-known scaled scoring 
described within specialized literature, such as the Hamilton 
scale, the Beck’s Depression and Anxiety Inventory, the 
Zung Self-rating Depression Scale and Hospital Anxiety 
and Depression Scale [12].
A quantitative and qualitative informative algorithm is 
particularly important for accurate assessment of depression 
and anxiety symptoms associated with epilepsy in women, 
thus the Hospital Anxiety and Depression-Anxiety (HAD – 
A) and Hospital Anxiety and Depression-Depression (HAD 
– D) scales were selected for screening [13]. The HAD scale 
includes the common signs of these 2 mental disorders, 
being easily applicable since no somatic signs are necessary, 
as well as quite applicable and effective in conducting re-
search studies in the Republic of Moldova.
Material and methods
The retrospective cohort analytical study was carried 
out in women of reproductive age (aged 15 - 49 years old) 
and included a sample of 128 women with epilepsy. Patients 
were enrolled via a primary outpatient consultation and a 
dynamic patient’s assessment, being admitted to hospital 
with an increasingly recurrent ES and serial ES that show 
risk of developing into Status Epilepticus. The characteris-
tics of the patients are displayed in table 1.
Table 1.  general characteristics of patients
Parameters Average or number SD or %















Type of ES. Total 130 122.9
Generalized 155 ES 121%
Focal 227 ES 177.3%
not defined 8 ES 6.25%
ES incidence over the past year. Total 1282 2646
1/365 days 12w 9.4%
1/180days 11w 8.6%






free ES 15w 11.7%
Disease duration (years) 3.5 3.6
0 years 21w 16.4%
1 year 5w 3.9%
2 years 16w 12.5%
3years 27w 21.1%
5years 11w 8.6%
10 years 47w 36.7%
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Table 2.  A and D distribution depending on ES type
Item Total Focal ES Generalized ES Focal ES Generalized ES
Anxiety 79w – 1.7% 61w – .2% 18w – 2.7% 19w–32% 22w – 3.6%
I feel tense or wound up (points) 170p 132p 38p
I get a sort of frightened feeling as if something awful is 
about to happen
164 126 38
Worrying thoughts go through my mind 171 129 42
I can't sit at ease and feel relaxed 129 99 30
I get a sort of frightened like ”butterflies” in the stomach 120 96 24
I feel restless as if I have to be on the move 119 93 26
I get sudden feelings of panic 143 105 38
Total 1016 points 780 points 236 points
Depression 41w – 32% 19w – 32% 22w – 53.6%
I still enjoy the things I used to enjoy 35p 54p
I can laugh and see the funny side of things 28 30
I feel cheerful 43 48
I feel as if I am slowed down 37 50
I have lost interest in my appearance 17 44
I look forward with enjoyment to things 42 36
I can enjoy a good book or TV program 43 50
Total 245 points 312 points
Table 3.  Distribution of HAD-A and HAD-D test response
Anxiety WWFS WWGS Depression 
7 groups of questions A 61w D19w A 18w D 7 groups of questions
0 0 5 0 0 0
1 15 0 6 2 1
2 18 6 4 2 2
3 27 6 8 16 3
0 3 1 0 0 0
1 9 4 4 10 1
2 30 4 8 4 2
3 18 5 6 4 3
0 6 0 0 0 0
1 6 3 4 8 1
2 27 8 4 6 2
3 21 8 10 8 3
0 0 2 2 2 0
1 15 7 8 2 1
2 24 2 4 8 2
3 18 8 6 10 3
0 15 2 6 2 0
1 18 2 8 6 1
2 18 5 2 6 2
3 9 10 2 8 3
0 9 2 2 2 0
1 27 2 10 2 1
2 15 7 4 12 2
3 9 8 2 6 3
0 9 0 2 0 0
1 18 4 8 4 1
2 27 6 0 8 2
3 9 9 8 10 3
Total score
8 – 10 p 18w/29,5% 3w/15.7% 8w/44.4% 4w/18.2% Borderline levels A/D
11 – 14p 24w/39.3% 8w/42.1% 6w/33.3% 10w/45.5% Medium levels A/D
15 – 21p 19w/31.1% 8w/42.1% 4w/22% 8w/36.3% Higher leves A/D
Note: WWFS – women with focal seizures, WWGS – women with generalized seizures.
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The ES diagnosis was made, based on its definition and 
ES diagnostic criteria settled by the International League 
Against Epilepsy (ILAE) [14]. The 1981 ILAE Classification 
of the epilepsy [15] was used in diagnosing the ES type.
According to the purpose of the research, depression and 
anxiety disorders were selected as factors being the most 
commonly associated with epilepsy, particularly in women. 
The assessment of depression and anxiety was based on the 
Hospital Anxiety and Depression Scale (HADS), which was 
considered sufficiently relevant. This method was designed 
in 1983 and includes 14 questions, 7 of which refer to A: 
HAD – A, and 7 are characteristic of D: HAD – D [16]. The 
assessment score was divided into 3 categories in both HAD 
– A and HAD – D scales, thus: I.> 7 – shows no A or D 
signs; II. 8-10 p – A / D milder form; III. 11-14 p – moder-
ate form; IV. 15-21p – severe form. The A and D signs were 
separately assessed. The specialized literature shows that the 
sensitivity for HAD-A is 93.7% and for HAD-D is 84.6%, 
whereas specificity makes up 72.6% for HAD-A and 90.3% 
for HAD-D [16].
Patients with atypical signs and severe anxiety and de-
pressive disorders with past medical history of psychiatric 
monitoring were excluded from the study.
HAD was administered by a resident-neurologist and 
specialist-neurologist based on the patient's informed con-
sent. Patients were informed to select responses spontane-
ously, based on their sensations and experiences.
The statistical analysis was performed via SPSS, the data 
being represented by the mean and the standard deviation 
values, which were applied to possible parameters. 
Results
The ES, depression and anxiety characteristics were ex-
amined in 128 WWE, aged 15-49 years, the mean age was 
30.2 ± 11 years. The study inclusion criteria were as follow-
ing: all types of ES associated with depression and anxiety 
symptoms, except for severe and atypical forms of mental 
disorders. 79 (61.7%) patients showed signs of anxiety and 
41 (32%) patients – depressive signs. 61 (77.2%) patients 
with anxiety suffered from simple and complex focal sei-
zures (FS) and 18 (22.7%) – primary and secondary gen-
eralized seizures (GS), showing predominantly significant 
values compared to patients with depression. Signs of de-
pression were found in 41 patients, whereas 19 patients 
(32%) exhibited FS and 22 (53.6%) – GS. Depending on the 
severity of the mental disorders, women with FS showed a 
more pronounced anxiety and made up 39.3% of medium 
severe cases (HAD-A scored 11-14p) and 31.1% of severe 
cases (HAD-A score 15-21p) compared to women with GS. 
The group of GS patients showed anxiety disorders in 33.3% 
of moderate to severe cases and in 22.1% of severe cases, 
depending on the HAD-A score.
The higher incidence of depressive symptoms was re-
corded in GS women – 53.6% of cases vs FS – 32% of pa-
tients. Moreover, depending on the disease severity, moder-
ate-to-severe signs of depression were recorded via HAD-D 
score of 11-14 that were slightly more pronounced in GS 
cases, and accounted for 45.5% vs. 42.1% of FS cases, respec-
tively.  However, signs of severe depression were determined 
in the group of patients with FS – 42.15% vs 36.3% in wom-
en with GS. The anxiety and depression signs, as well as the 
quantified response were distributed according to the type of 
epileptic seizure that is shown in tables 2 and 3.
The obtained study results of the correlation between 
the frequency of epileptic seizures with anxiety and de-
pression, revealed a directly proportional relation between 
these parameters in 93.7% of cases. Thus, the HAD-A and 
HAD-D score showed high levels of 15-21 in recurrent ES 
cases, ranging from 1ES / day, 1ES / week to 1ES/month, 
in both types of mental disorders. The recurrent ES cases 
ranging from 1ES / month and 1ES/year, the HADS score 
had a mean value of 11-14 p. respectively, without revealing 
any prevalence in 41 patients with depression or 79 patients 
suffering from anxiety. The 8-10 HADS score registered pa-
tients with 1 / year or less than 1 / year ES recurrence, as well 
as seizure-free patients for over 1 year.
The disease duration over 5 years, as well as over 10 years 
determined an increasing tendency of depression signs with 
15-21 HAD-D score in 65% vs anxiety HAD-A in 53% of 
cases. Anxiety was determined in 57% of cases, predomi-
nantly found in the group of patients with 0-2 years of dis-
ease duration with a score of 15-21 HAD-A vs depression 
– found in 18% of cases. 
Discussion
The results of this study showed a significant correlation 
between epilepsy in women and anxiety and depression that 
was determined in the dynamics of epileptic disease. The 
HADS scaled score proved to be sufficiently relevant to as-
sess the prevalence of anxiety and depression disorders, de-
pending on the type and recurrence of seizures, as well as 
on the disease duration. The research results confirmed that 
the disease chronicity has a greater impact on depression 
vs anxiety, being a major risk factor for developing mental 
disorders in epilepsy [17]. This study revealed about 90% 
incidence rate of anxiety and depression in the group of 
women of reproductive age, suffering from epilepsy for over 
1 to 10 years. However, some depression and anxiety dis-
orders were likely to be caused by several endogenous and 
constitutive factors, such as hereditary tendency, antiepilep-
tic medication, non-diagnosed early mental symptoms, etc.
As regarding the ES type, it has been proven that it had a 
less impact on the development of mental disorders compared 
to the ES recurrence and disease duration. However, focal ES 
has been mostly associated with anxiety, whereas generalized 
ES referred to different types of depressive disorders. 
Women with high depression and anxiety severity levels 
established via HADS score are recommended to be further 
checked by psychiatrist and undergo a more complex psy-
chometric scale assessment in order to prevent serious men-
tal disorders and initiate an early psychiatric treatment [18].
Conclusions
The analysis of the depression and anxiety symptoms 
associated with epilepsy in women of reproductive age re-
vealed the following:
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1. Depression and anxiety comorbidity in epilepsy exhibit 
a heterogeneous nature, determined by the polymor-
phism of the clinical signs.
2. The HADS scale was sufficiently relevant for screening 
anxiety and depression disorders associated with epi-
lepsy in women aged 15-49 years. 
3. The disease duration and the recurrent epileptic sei-
zures are major risk factors for developing depression 
and anxiety in epilepsy women.
4. Correlation between anxiety and depression and the ES 
type is quite controversial, thus requiring further stud-
ies by using instrumental investigations, such as global 
neuroimaging and electroencephalography studies, as 
well as the analysis of antiepileptic drug therapy.
5. The anxiety and depression disorders in women with 
epilepsy might be potentially diagnosed earlier if ap-
plying the screening HADS scale assessment in pri-
mary and dynamic neurological examination of all 
patients with epilepsy, in order to identify early signs 
of mental disorders, prevent suicide attempts, improve 
the quality of life and manage proper treatment.
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